Featured Publications
A phenomapping-derived tool to personalize the selection of anatomical vs. functional testing in evaluating chest pain (ASSIST)
Oikonomou EK, Van Dijk D, Parise H, Suchard MA, de Lemos J, Antoniades C, Velazquez EJ, Miller EJ, Khera R. A phenomapping-derived tool to personalize the selection of anatomical vs. functional testing in evaluating chest pain (ASSIST). European Heart Journal 2021, 42: 2536-2548. PMID: 33881513, PMCID: PMC8488385, DOI: 10.1093/eurheartj/ehab223.Peer-Reviewed Original ResearchConceptsStable chest painChest painPrimary endpointMajor adverse cardiovascular eventsNon-fatal myocardial infarctionAdverse cardiovascular eventsStudy's primary endpointCoronary artery diseaseClinical trial populationsCox regression modelParticipant-level dataSCOT-HEARTCardiovascular eventsCause mortalityHazard ratioPatients 5Artery diseaseFunctional testingPROMISE trialTrial populationMyocardial infarctionLower incidenceStudy populationPainCollected variables
2023
DOACs or warfarin use in morbidly obese patients (BMI > 40 kg/m2) on anticoagulant therapy? : a systematic review and meta-analysis
Sagris M, Ktenopoulos N, Pamporis K, Theofilis P, Oikonomou E, Tsioufis K, Tousoulis D. DOACs or warfarin use in morbidly obese patients (BMI > 40 kg/m2) on anticoagulant therapy? : a systematic review and meta-analysis. European Heart Journal 2023, 44: ehad655.2537. DOI: 10.1093/eurheartj/ehad655.2537.Peer-Reviewed Original ResearchDirect oral anticoagulantsSafety of DOACsMinor bleeding eventsMorbidly obese patientsVenous thromboembolismObese patientsDOAC useAtrial fibrillationBleeding eventsWarfarin groupComposite endpointMajor bleeding ratesFirst-line treatmentOral anticoagulation therapyAnticoagulation indicationsDOAC groupSystematic embolismWarfarin useAnticoagulation therapyCause mortalityOral anticoagulantsSecondary endpointsAnticoagulant therapyIschemic strokePrimary outcome